These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 30995651

  • 1. The Effect of Gonadotropin-Releasing Hormone Analogue on Final Adult Height in Children with Idiopathic Short Stature.
    Khawaja N, Owaineh H, Batieha A, Frahid O, El-Khateeb M, Ajlouni KM.
    Med Princ Pract; 2019; 28(6):509-516. PubMed ID: 30995651
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R, Gunczler P.
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [Abstract] [Full Text] [Related]

  • 4. Combined therapy with GnRH analogue and growth hormone increases adult height in children with short stature and normal pubertal onset.
    Li S, Wang X, Zhao Y, Ji W, Mao J, Nie M, Wu X.
    Endocrine; 2020 Sep; 69(3):615-624. PubMed ID: 32533506
    [Abstract] [Full Text] [Related]

  • 5. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM, Pucarelli I, Roggini M, Segni M.
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [Abstract] [Full Text] [Related]

  • 6. [Effect of gonadotropin-releasing hormone analog combined with stanazolol on final height in girls with idiopathic central precocious puberty and apparent decrease of linear growth].
    Li YH, Zhu SY, Ma HM, Su Z, Chen HS, Chen QL, Gu YF, Du ML.
    Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):807-12. PubMed ID: 24484553
    [Abstract] [Full Text] [Related]

  • 7. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience.
    Kohn B, Julius JR, Blethen SL.
    Pediatrics; 1999 Oct; 104(4 Pt 2):1014-8. PubMed ID: 10506254
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of combined treatment with growth hormone and gonadotropin releasing hormone analogue in children with poor prognosis of adult height.
    Toumba M, Bacopoulou I, Savva SC, Skordis N.
    Indian Pediatr; 2007 Jul; 44(7):497-502. PubMed ID: 17684302
    [Abstract] [Full Text] [Related]

  • 9. A meta-analysis of combination therapy with gonadotrophin-releasing hormone agonist and growth hormone for children with idiopathic short stature and normal timed puberty.
    Zhou B, Liu S, Wang J, Zhang T, Yuan Y, Niu W, Zhang Z, Wang L.
    Endocrine; 2022 Mar; 75(3):698-708. PubMed ID: 35083638
    [Abstract] [Full Text] [Related]

  • 10. The Beneficial Effect of Combined GH/GnRHa Therapy in Increasing Adult Height Outcome in Children With ISS.
    Lazar L, Levy S, Oron T, Meyerovitch J, de Vries L, Shalitin S, Tenenbaum A, Phillip M, Lebenthal Y.
    J Clin Endocrinol Metab; 2019 Aug 01; 104(8):3287-3295. PubMed ID: 30912806
    [Abstract] [Full Text] [Related]

  • 11. Expensive therapies in children: benefit versus cost of combined treatment of recombinant human growth hormone and gonadotropin-releasing hormone analogue in girls with poor height potential.
    Toumba M, Kokotsis V, Savva SC, Skordis N.
    J Pediatr Endocrinol Metab; 2014 Mar 01; 27(3-4):311-6. PubMed ID: 24158419
    [Abstract] [Full Text] [Related]

  • 12. Final adult height of children with idiopathic short stature: a multicenter study on GH therapy alone started during peri-puberty.
    Wu D, Chen RM, Chen SK, Liu GL, Chen LQ, Yang Y, Wang XL, Peng YG, Gong CX.
    BMC Pediatr; 2020 Mar 28; 20(1):138. PubMed ID: 32222149
    [Abstract] [Full Text] [Related]

  • 13. Puberty and Pubertal Growth in GH-treated SGA Children: Effects of 2 Years of GnRHa Versus No GnRHa.
    van der Steen M, Lem AJ, van der Kaay DC, Hokken-Koèelega AC.
    J Clin Endocrinol Metab; 2016 May 28; 101(5):2005-12. PubMed ID: 26964733
    [Abstract] [Full Text] [Related]

  • 14. [Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].
    Ságodi L, Sólyom E, Lombay B, Almási A, Vámosi I.
    Orv Hetil; 2012 Mar 18; 153(11):418-24. PubMed ID: 22390866
    [Abstract] [Full Text] [Related]

  • 15. Effect of gonadotropin-releasing hormone agonist monotherapy and combination therapy with growth hormone on final adult height in girls with central precocious puberty.
    Cho AY, Shim YS, Lee HS, Hwang JS.
    Sci Rep; 2023 Jan 23; 13(1):1264. PubMed ID: 36690835
    [Abstract] [Full Text] [Related]

  • 16. Comparative efficacy of aromatase inhibitors and gonadotropin-releasing hormone analogue in increasing final height of idiopathic short stature boys: a network meta-analysis.
    Wang S, Wu Z, Chen Y, Luo K, Cui Z, Zhang J, Zheng J, Xiao K, Li H.
    Front Endocrinol (Lausanne); 2023 Jan 23; 14():1167351. PubMed ID: 37124748
    [Abstract] [Full Text] [Related]

  • 17. The effects of gonadotropin-releasing hormone agonist on final adult height among girls with early and fast puberty.
    Tseng CH, Lee YJ, Huang CY, Wu YL, Wang LT, Lin CH, Cheng BW, Lo FS, Chang YJ, Ting WH.
    Front Endocrinol (Lausanne); 2023 Jan 23; 14():1271395. PubMed ID: 38027198
    [Abstract] [Full Text] [Related]

  • 18. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.
    Poomthavorn P, Suphasit R, Mahachoklertwattana P.
    Gynecol Endocrinol; 2011 Aug 23; 27(8):524-8. PubMed ID: 21501002
    [Abstract] [Full Text] [Related]

  • 19. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA, Mul D, Waelkens JJ, Jansen M, Delemarre-van de Waal HA, Verhoeven-Wind L, Frölich M, Oostdijk W, Wit JM.
    J Clin Endocrinol Metab; 2001 Jul 23; 86(7):2969-75. PubMed ID: 11443153
    [Abstract] [Full Text] [Related]

  • 20. Final height outcome after three years of growth hormone and gonadotropin-releasing hormone agonist treatment in short adolescents with relatively early puberty.
    van Gool SA, Kamp GA, Visser-van Balen H, Mul D, Waelkens JJ, Jansen M, Verhoeven-Wind L, Delemarre-van de Waal HA, de Muinck Keizer-Schrama SM, Leusink G, Roos JC, Wit JM.
    J Clin Endocrinol Metab; 2007 Apr 23; 92(4):1402-8. PubMed ID: 17284626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.